Platelet-derived growth factor, intimal hyperplasia, and ischemic complications in giant cell arteritis

Arthritis and Rheumatism

Volumn 41, Issue 4, 1998, Pages 623-633

  Kaiser, Markus ^a   Weyand, Cornelia M ^a   Björnsson, Johannes ^a   Goronzy, Jörg J ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLATELET DERIVED GROWTH FACTOR A; PLATELET DERIVED GROWTH FACTOR B;

AORTA ARCH SYNDROME; ARTERY INTIMA PROLIFERATION; ARTICLE; ATHEROSCLEROSIS; CLAUDICATION; CLINICAL FEATURE; GIANT CELL ARTERITIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; ISCHEMIA; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN DETERMINATION; TEMPORAL ARTERY;

BRAIN ISCHEMIA; HUMANS; HYPERPLASIA; IMMUNOHISTOCHEMISTRY; MACROPHAGES; PLATELET-DERIVED GROWTH FACTOR; TEMPORAL ARTERIES; TEMPORAL ARTERITIS; TUNICA INTIMA;

EID: 0031901492     PISSN: 00043591     EISSN: None     Source Type: Journal    
DOI: 10.1002/1529-0131(199804)41:4<623::AID-ART9>3.0.CO;2-6     Document Type: Article

References (39)

1. Hunder GG. Giant cell arteritis and polymyalgia rheumatica. Med Clin North Am 1997;81:195-219.
2. Lie JT, and Members and Consultants of the American College of Rheumatology Subcommittee on Classification of Vasculitis. Illustrated histopathologic classification criteria for selected vasculitis syndromes. Arthritis Rheum 1990;33:1074-87.
3. Baldursson Ó, Steinsson K, Björnsson J, Lie JT. Giant cell arteritis in Iceland: an epidemiologic and histopathologic analysis. Arthritis Rheum 1994;37:1007-12.
4. Weyand CM, Goronzy JJ. Giant cell arteritis as an antigen driven disease. Rheum Dis Clin North Am 1995;21:1027-39.
5. Wagner AD, Björnsson J, Bartley GB, Goronzy JJ, Weyand CM. Interferon gamma producing T cells in giant cell vasculitis represent a minority of tissue infiltrating cells and are located distant from the site of pathology. Am J Pathol 1996;148:1925-33.
6. Weyand CM, Wagner AD, Björnsson J, Goronzy JJ. Correlation of topographical arrangement and the functional pattern of tissue-infiltrating macrophages in giant cell arteritis. J Clin Invest 1996;98:1642-9.
7. Allen NB, Studenski SA. Polymyalgia rheumatica and temporal arteritis. Med Clin North Am 1986;70:369-84.
8. Machado EBV, Michet CJ, Ballard DJ, Hunder GG, Beard CM, Chu C-P, et al. Trends in incidence and clinical presentation of temporal arteritis in Olmsted County, Minnesota, 1950-1985. Arthritis Rheum 1988;31:745-9.
9. Evans JM, O'Fallon WM, Hunder GG. Increased incidence of aortic aneurysm and dissection in giant cell (temporal) arteritis: a population-based study. Ann Intern Med 1995;122:502-7.
10. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993;362:801-9.
11. Ross R. The pathogenesis of atherosclerosis - an update. N Engl J Med 1986;314:488-500.
12. MacLeod DC, Strauss BH, de Jong M, Escaned J, van Suylen R-J, Serruys PW, et al. Proliferation and extracellular matrix synthesis of smooth muscle cells cultured from human coronary atherosclerotic and restenotic lesions. J Am Coll Cardiol 1994;23:59-65.
13. O'Brien ER, Schwartz SM. Update on the biology and clinical study of restenosis. Trends Cardiovasc Med 1994;4:165-78.
14. Ross R, Raines EW, Bowen-Pope DF. The biology of platelet-derived growth factor. Cell 1986;46:155-69.
15. Hart CE, Forstron JW, Kelly JD, Siefert RA, Smith RA, Ross R, et al. Two classes of PDGF receptor recognize different isoforms of PDGF. Science 1988;240:1529-31.
16. Heldin CH, Westermark B. Platelet-derived growth factor: mechanism of action and possible in vivo function. Cell Regulation 1990;1:555-66.
17. Jawien A, Bowen-Pope DF, Linder V, Schwartz SM, Clowes AW. Platelet-derived growth factor promotes smooth muscle migration and intimal thickening in a rat model of balloon angioplasty. J Clin Invest 1992;89:507-11.
18. Uchida K, Sasahara M, Morigami N, Hazama F, Kinoshita M. Expression of platelet-derived growth factor B-chain in neointimal smooth muscle cells of balloon injured rabbit femoral arteries. Atherosclerosis 1996;124:9-23.
19. Hunder GG, Bloch DA, Michel BA, Stevens MB, Arend WP, Calabrese LH, et al. The American College of Rheumatology 1990 criteria for the classification of giant cell arteritis. Arthritis Rheum 1990;33:1122-8.
20. + cells in giant cell arteritis: evidence for two components of the disease. J Clin Invest 1994; 94:1134-40.
21. Nikkari ST, Hoythya M, Isola J, Nikkari T. Macrophages contain 92-kd gelatinase (MMP-9) at the site of degenerated internal elastic lamina in temporal arteritis. Am J Pathol 1996;149:1427-33.
22. Hafner V, Rittner HL, Younge B, Goronzy JJ, Weyland CM. Reactive oxygen intermediates and cellular detoxification systems in vascular damage associated with giant cell vasculitis [abstract]. Arthritis Rheum 1997;40 Suppl 9:S69.
23. McCaffrey TA, Pomerantz KB, Sanborn TA, Spolojny AM, Du B, Park MH, et al. Specific inhibition of EIF-5A and collagen hydroxylation by a single agent: antiproliferative fibrosuppressive effects on smooth muscle cells from human coronary arteries. J Clin Invest 1995;95:446-55.
24. O'Brien ER, Alopers CE, Stweart DK, Ferguson M, Tran N, Gordon D, et al. Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 1993;73:223-31.
25. Ross R, Masuda J, Raines EW, Gown AM, Katsuda S, Sasahara M, et al. Localization of PDGF-B protein in macrophages in all phases of atherogenesis. Science 1990;248:1009-12.
26. Hughes AD, Clunn GF, Nelson J, Demolion-Mason C. Platelet-derived growth factors: actions and mechanisms in vascular smooth muscle. Gen Pharmacol 1996;27:1079-89.
27. Abedi H, Zachary I. Signaling mechanisms in the regulation of vascular cell migration. Cardiovasc Res 1995;30:544-56.
28. Rothman A, Wolner B, Button D, Taylor P. Immediate-early gene expression in response to hypertrophic and proliferative stimuli in pulmonary arterial smooth muscle cells. J Biol Chem 1994;269: 6399-404.
29. Bowen-Pope DF, Hart CE, Seifert RA. Sera and conditioned media contain different isoforms of platelet-derived growth factor (PDGF) which bind to different classes of PDGF receptor. J Biol Chem 1989;264:2502-8.
30. Wilcox JN, Smith KM, Williams LT, Schwartz SM, Gordon D. Platelet-derived growth factor mRNA detection in human atherosclerotic plaques by in situ hybridization. J Clin Invest 1988;82: 1134-43.
31. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM. PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990;111:554-9.
32. Sachinidis A, Locher R, Vetter W, Tatje D, Hoppe J. Different effects of platelet-derived growth factor isoforms on rat vascular smooth muscle cells. J Biol Chem 1990;265:10238-43.
33. Ueda M, Becker AE, Kasayuki N, Kojma A, Morita Y, Tanaka S. In situ detection of platelet-derived growth factor-A and -B chain mRNA in human coronary arteries after percutaneous transluminal coronary angioplasty. Am J Pathol 1996;145:831-43.
34. Kraiss LW, Raines EW, Wilcox JN, Siefert RA, Barrett TB, Kirkman TR, et al. Regional expression of the platelet-derived growth factor and its receptors in a primate graft model of vessel wall assembly. J Clin Invest 1993;92:338-48.
35. Alpers CE, Davis CL, Barr D, Marsh CL, Hidkins KL. Identification of platelet-derived growth factor A and B chains in human renal vascular rejection. Am J Pathol 1996;148:439-51.
36. Newby AC, Southgate KM, Davies M. Extracellular matrix degrading metalloproteinase in the pathogenesis arteriosclerosis. Basic Res Cardiol 1994;89 Suppl:59-70.
37. Weyand CM, Tetzlaff N, Björnsson J, Brack A, Younge B, Goronzy JJ. Disease patterns and tissue cytokine profiles in giant cell arteritis. Arthritis Rheum 1997;40:19-26.
38. Brack A, Rittncr HL, Younge BR, Kaltschmidt C, Weyand CM, Goronzy JJ. Glucocorticoids mediated repression of cytokine gene transcription in human arteritis-SCID chimeras. J Clin Invest 1997;99:2842-50.
39. Khachigian LM, Resmick N, Gimbrone MA, Collius T. Nuclear factor-kappa B interacts functionally with the platelet-derived growth factor B-chain shear-stress response element in vascular endothelial cells exposed to fluid shear stress. J Clin Invest 1995;96:1169-75.